Front-line workers for the United Kingdom’s National Health Service will be able to test personally whether the anti-malarial drug hydroxychloroquine works to prevent the coronavirus.

Up to 10,000 NHS workers will participate in a trial of the drug touted by President Trump to see if it prevents the coronavirus. The clinical trial will be a global effort, with participants joining from Europe, Africa, Asia, and South America.

Recommended Stories

WHO suspends hydroxychloroquine trials

Fauci: ‘Quite evident’ that hydroxychloroquine does not treat COVID-19

New study shows hydroxychloroquine ‘may be a benefit’ in treating the coronavirus after all